Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-002875)

Filing Details

Accession Number:: 0001181431-12-002875
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-01-18 15:29:37
Reporting Period:: 2012-01-13

Filing Date:: 2012-01-18
Accepted Time:: 2012-01-18 15:29:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
819050	Vical Inc	VICL	Biological Products, (No Disgnostic Substances) (2836)	930948554

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1198237	Phd P Alain Rolland	10390 Pacific Center Court San Diego CA 92121	Exec Vp, Product Development	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock $.01 Par Value	Acquisiton	2012-01-13	27,000	$0.01	171,563	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2012-01-13	29,875	$0.00	29,875	$3.67
Common Stock	Nonstatutory Stock Option (right to buy)	Acquisiton	2012-01-13	117,125	$0.00	117,125	$3.67

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
639,875	2013-01-13	2022-01-12	No	4	A	Direct
757,000	2013-01-13	2022-01-12	No	4	A	Direct

Footnotes

Share were acquired pursuant to a restricted stock grant.
The right to exercise the above stock options generally vests 25% on the first anniversary date of the grant, with the remaining rights vesting quarterly over the remaining three years.
This balance includes 105,750 of unvested restricted stock units.